MEI PHARMA INC's ticker is MEIP and the CUSIP is 55279B202. A total of 38 filers reported holding MEI PHARMA INC in Q3 2014. The put-call ratio across all filers is 1.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $19,000 | -17.4% | 13,316 | 0.0% | 0.01% | -22.2% |
| Q3 2016 | $23,000 | +27.8% | 13,316 | 0.0% | 0.01% | +28.6% |
| Q2 2016 | $18,000 | +5.9% | 13,316 | 0.0% | 0.01% | -12.5% |
| Q1 2016 | $17,000 | -19.0% | 13,316 | 0.0% | 0.01% | -20.0% |
| Q4 2015 | $21,000 | -12.5% | 13,316 | -13.5% | 0.01% | -16.7% |
| Q3 2015 | $24,000 | -7.7% | 15,399 | 0.0% | 0.01% | 0.0% |
| Q2 2015 | $26,000 | -7.1% | 15,399 | 0.0% | 0.01% | -7.7% |
| Q1 2015 | $28,000 | -57.6% | 15,399 | 0.0% | 0.01% | -60.6% |
| Q4 2014 | $66,000 | -25.8% | 15,399 | +19.4% | 0.03% | -31.2% |
| Q3 2014 | $89,000 | +8.5% | 12,899 | +0.0% | 0.05% | +11.6% |
| Q2 2014 | $82,000 | -44.6% | 12,896 | -2.7% | 0.04% | -50.6% |
| Q1 2014 | $148,000 | +39.6% | 13,253 | 0.0% | 0.09% | +24.3% |
| Q4 2013 | $106,000 | -40.8% | 13,253 | -16.8% | 0.07% | -45.7% |
| Q3 2013 | $179,000 | +57.0% | 15,931 | 0.0% | 0.13% | +55.4% |
| Q2 2013 | $114,000 | – | 15,931 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 3,018,059 | $4,467,000 | 4.40% |
| CAXTON CORP | 885,560 | $1,426,000 | 1.56% |
| Vivo Capital, LLC | 9,784,422 | $15,753,000 | 1.43% |
| Sio Capital Management, LLC | 2,485,098 | $4,001,000 | 1.34% |
| BVF INC/IL | 5,046,272 | $8,124,000 | 0.76% |
| NEA Management Company, LLC | 8,533,072 | $13,738,000 | 0.72% |
| Boxer Capital, LLC | 2,913,091 | $4,690,000 | 0.32% |
| Perceptive Advisors | 3,030,440 | $4,879,000 | 0.13% |
| WASATCH ADVISORS LP | 5,070,718 | $8,164,000 | 0.08% |
| KNOTT DAVID M | 38,590 | $62,000 | 0.04% |